Mel Soliz Examines EHR Competition & Data Access Implications of FTC’s Epic Investigation in Healthcare Innovation
Healthcare Innovation recently tapped Partner Mel Soliz for insight on the U.S. Federal Trade Commission's new antitrust investigation of Epic Systems and the broader questions now surfacing around market concentration and data access in the health technology space. Mel discussed the factors that can generally trigger an investigation and what this could mean for today’s providers, EHR vendors, and health tech companies. Notably, she emphasized that while information blocking rules and antitrust laws operate under distinct legal standards, they can scrutinize the same conduct when restrictions on health data exchange also disadvantage competitors. Mel’s practice focuses on health data interoperability, privacy, complex data-sharing arrangements, health information networks and exchanges, technology contracting, and related regulatory and litigation risk. Read the full interview....
Read MoreRead More